This inventor holds 1 USPTO granted patent. Top assignee: Korea Advanced Institute of Science and Technology. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Innovations of Won Kyong Kim in Artificial ncRNA Technology.
Introduction: Won Kyong Kim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of artificial non-coding RNA (ncRNA) technologies. His work focuses on enhancing the stability and functionality of artificial ncRNA, which has important implications for genetic research and therapeutic applications.
Latest Patents: Won Kyong Kim holds a patent for a "Genome-originated artificial ncRNA expression library and method of preparing the same." This invention relates to an artificial ncRNA expression library and a method for preparing it. The innovation secures the stability of artificial ncRNA by cloning random fragmented DNA from whole genome DNA, which is then integrated into an RNA scaffold featuring a double stem-loop structure. This method represents a significant advancement in the preparation of stable artificial ncRNA libraries.
Career Highlights: Won Kyong Kim is affiliated with the Korea Advanced Institute of Science and Technology (KAIST), where he conducts his research. His work has garnered attention for its potential applications in various fields, including gene therapy and molecular biology. His innovative approach to ncRNA technology has positioned him as a key figure in the biotechnology sector.
Collaborations: Some of his notable coworkers include Younghoon Lee and Jee Soo Choi. Their collaborative efforts contribute to the advancement of research in artificial ncRNA technologies.
Conclusion: Won Kyong Kim's contributions to the field of artificial ncRNA technology highlight his innovative spirit and dedication to advancing biotechnology. His patent and ongoing research efforts continue to pave the way for new developments in genetic engineering and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
